These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15642420)

  • 1. The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases.
    Leidenius MH; Vironen JH; Riihelä MS; Krogerus LA; Toivonen TS; von Smitten KA; Heikkilä PS
    Eur J Surg Oncol; 2005 Feb; 31(1):13-8. PubMed ID: 15642420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis.
    Houvenaeghel G; Nos C; Giard S; Mignotte H; Esterni B; Jacquemier J; Buttarelli M; Classe JM; Cohen M; Rouanet P; Penault Llorca F; Bonnier P; Marchal F; Garbay JR; Fraisse J; Martel P; Fondrinier E; Tunon de Lara C; Rodier JF
    Eur J Surg Oncol; 2009 Jul; 35(7):690-5. PubMed ID: 19046847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node.
    Schrenk P; Konstantiniuk P; Wölfl S; Bogner S; Haid A; Nemes C; Jagoutz-Herzlinger M; Redtenbacher S
    Br J Surg; 2005 Jun; 92(6):707-13. PubMed ID: 15810047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P; Capdet J; Méry E; Zerdoud S; Ferron G; Rafii A; Roché H; Querleu D
    Bull Cancer; 2008; 95(7):763-72. PubMed ID: 18755653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
    Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node.
    Farshid G; Pradhan M; Kollias J; Gill PG
    Breast; 2004 Dec; 13(6):494-501. PubMed ID: 15563857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node.
    Tvedskov TF; Bartels A; Jensen MB; Paaschburg B; Kroman N; Balslev E; Brünner N
    APMIS; 2011 Dec; 119(12):844-52. PubMed ID: 22085360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours.
    Leidenius MH; Krogerus LA; Toivonen TS; von Smitten KA
    Eur J Surg Oncol; 2005 May; 31(4):364-8. PubMed ID: 15837040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
    Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
    Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of non-sentinel metastases in primary breast cancer.
    Bauerfeind IG; Kahlert S; Himsl I; Sorokina Y; Ruehl IM; Lebeau A; Linke R; Untch M; Friese K
    Anticancer Res; 2007; 27(4A):1929-32. PubMed ID: 17649798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of and risk factors for four or more metastatic axillary lymph nodes in breast cancer patients undergoing sentinel node biopsy.
    Leidenius M; Vaalavirta L; Heikkilä P; von Smitten K; Salmenkivi K
    J Surg Oncol; 2008 Jul; 98(1):21-6. PubMed ID: 18484087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for non-sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study.
    Bolster MJ; Peer PG; Bult P; Thunnissen FB; Schapers RF; Meijer JW; Strobbe LJ; van Berlo CL; Klinkenbijl JH; Beex LV; Wobbes T; Tjan-Heijnen VC
    Ann Surg Oncol; 2007 Jan; 14(1):181-9. PubMed ID: 17028772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-positive sentinel node findings in patients with ductal carcinoma in situ.
    Leidenius M; Salmenkivi K; von Smitten K; Heikkilä P
    J Surg Oncol; 2006 Oct; 94(5):380-4. PubMed ID: 16967467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer.
    Fink AM; Lass H; Hartleb H; Jurecka W; Salzer H; Steiner A
    Ann Surg Oncol; 2008 Mar; 15(3):848-53. PubMed ID: 18043975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sentinel node biopsy without systematic axillary dissection: study about 1000 procedures].
    Giard S; Chauvet MP; Houpeau JL; Baranzelli MC; Carpentier P; Fournier C; Belkacemi Y; Bonneterre J
    Gynecol Obstet Fertil; 2005 Apr; 33(4):213-9. PubMed ID: 15894205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sentinel lymph node biopsy in breast cancer].
    Schlichting E; Harr ME; Sauer T; Babovic A; Kåresen R
    Tidsskr Nor Laegeforen; 2006 Aug; 126(16):2098-100. PubMed ID: 16932777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low invasion in sentinel lymph node according to the European Working Group In Breast Screening Pathology (EWGBSP) recommendations and non sentinel invasion risk in breast cancer].
    Gauthier T; Fermeaux V; Mollard J; Aubard Y
    Gynecol Obstet Fertil; 2009 Jun; 37(6):481-7. PubMed ID: 19457697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.